In the absence of effective interventions to prevent preterm births, improved survival of
infants who are born at the biological limits of viability has relied on advances in perinatal …

Abstract In February 2018, the 6th World Symposium on Pulmonary Hypertension (WSPH)
brought together experts from various disciplines to review the most relevant clinical and …

Background In pulmonary hypertension subgroups, elevated pulmonary vascular resistance
(PVR) of 3· 0 Wood units or more is associated with poor prognosis. However, the spectrum …

The diagnosis and management of pulmonary arterial hypertension (PAH) includes several
advances, such as a broader recognition of extrapulmonary vascular organ system …

Rationale: Premature birth affects 10% of live births in the United States and is associated
with alveolar simplification and altered pulmonary microvascular development. However …

Major advances in pulmonary arterial hypertension, pulmonary hypertension (PH)
associated with lung disease, and chronic thromboembolic PH cast new light on the …

Preterm birth accounts for over 15 million global births per year. Perinatal interventions
introduced since the early 1980s, such as antenatal glucocorticoids, surfactant, and invasive …

Pulmonary hypertension (PH) is an independent risk factor for adverse clinical outcome,
particularly in left heart disease (LHD) patients. Recent advances have clarified the mean …

Background Recent studies have demonstrated a continuum in clinical risk related to mean
pulmonary artery pressure that begins at> 19 mm Hg, which is below the traditional …

Pulmonary hypertension (PH) describes a group of severe pulmonary vascular disorders
characterized by elevated mean pulmonary arterial pressure (mPAP) at rest. 1 The World …